Pratia’s Preventive Actions recognized by Reuters Events​

Pratia's Preventive Actions recognized by Reuters Events​!

The organizers of the competition appreciated the initiative of a mobile study for 1,350 Patients at risk of osteoporosis. Check the details of this unique action.

Pro-health Pratia campaigns were appreciated by the world's largest event agency, Reuters Events.

Thanks to our actions, Pratia made it to the finals of the Pharma Awards Europe 2022 in two categories: "Driving Health Equity Award" and "Delivering Inclusive Trials Award." Both categories are new, appearing for the first time in 2022.

Driving Health Equity Award

The winner of this award will be an initiative that has demonstrably worked to deliver on driving equitable access for patients in underserved communities – such includes but is not limited to educational programs, outreach and awareness campaigns, advocacy partnership, or research studies that helped to dismantle societal barriers to equitable medicine use.

Delivering Inclusive Trials Award

The winner of this award will be an initiative that has demonstrably worked to deliver clinical trials that excel in enabling diverse patient recruitment and retention. Having identified and addressed key burdens and participation barriers impacting underrepresented demographics, the winning project will have made critical changes to trial design and execution strategies that have a quantifiable impact.

Reuters Events, the organizer of the awards, appreciated the preventive campaigns conducted by Pratia in Poland and Bulgaria.

Particularly noteworthy is the "Examine your bones" initiative, the acceptance of which among Patients exceeded our wildest expectations.

Mobile densitometer: Osteobus visited as many as 28 cities and towns in Poland, thanks to which, during 52 free events, we examined 1,350 Patients exposed to osteoporosis. Women with positive results for osteoporosis have been invited to meet modern therapies within Clinical Trials that Pratia conducts. The goal of those Studies is to increase the availability of modern treatments for osteoporosis.

Furthermore, Pratia has organized another preventative action campaign in Poland for Non-Fatty Liver Disease in the Silesia region. Thanks to the FibroScan analysis, and outstanding dedication of the Medical Team, many Patients have found that they have medical conditions with their livers. The success of the awareness campaign for a practically unknown medical condition amongst the general population proved a success in achieving the targets for these Clinical Trials.

In Bulgaria, most of our Clinical Research Sites are located in the northern mountainous part of the country, covering 70% of the territory, giving extra access to Patients to innovative care. Through our collaboration with local healthcare systems, we can conduct Clinical Trials in many small cities in the country without putting extra pressure on Patients to travel far distances.

Pharma Awards Europe is a competition that identifies leaders, pioneers, and innovators in the pharmaceutical industry, delivering unprecedented value to customers and patients.

The final and award ceremony will take place on November 17.

Keep your fingers crossed!